The authors evaluated the outcome of recipients of alternative donor allogeneic stem cell transplantation for T-cell lymphoma.
[Bone Marrow Transplantation]
6445218
{6445218:XVB9YW6F}
apa
50
1
165531
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-65ea8aea9b88efc06eec2b03dbe4dd34%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XVB9YW6F%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cornillon%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECornillon%2C%20J.%2C%20Daguenet%2C%20E.%2C%20Tournilhac%2C%20O.%2C%20Blaise%2C%20D.%2C%20NGuyen%2C%20S.%2C%20Wallet%2C%20H.%20L.%2C%20Chevallier%2C%20P.%2C%20Dulery%2C%20R.%2C%20Forcade%2C%20E.%2C%20Srour%2C%20M.%2C%20Bazarbachi%2C%20A.%2C%20Contentin%2C%20N.%2C%20Lioure%2C%20B.%2C%20Tinquaut%2C%20F.%2C%20Bulabois%2C%20C.-E.%2C%20Rubio%2C%20M.-T.%2C%20Robin%2C%20M.%2C%20%26amp%3B%20Bay%2C%20J.-O.%20%282021%29.%20Allogeneic%20hematopoietic%20stem%20cell%20transplantation%20from%20unmanipulated%20haploidentical%20donor%20and%20unrelated%20cord%20blood%20for%20T-cell%20lymphoma%3A%20a%20retrospective%20study%20from%20the%20Soci%26%23xE9%3Bt%26%23xE9%3B%20Francophone%20de%20Greffe%20de%20Moelle%20et%20de%20Therapie%20Cellulaire.%20%3Ci%3EBone%20Marrow%20Transplantation%3C%5C%2Fi%3E%2C%201%26%23x2013%3B8.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-021-01426-3%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-021-01426-3%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DXVB9YW6F%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Allogeneic%20hematopoietic%20stem%20cell%20transplantation%20from%20unmanipulated%20haploidentical%20donor%20and%20unrelated%20cord%20blood%20for%20T-cell%20lymphoma%3A%20a%20retrospective%20study%20from%20the%20Soci%5Cu00e9t%5Cu00e9%20Francophone%20de%20Greffe%20de%20Moelle%20et%20de%20Therapie%20Cellulaire%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Cornillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Daguenet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Tournilhac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Blaise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22NGuyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helene%20Labussiere%22%2C%22lastName%22%3A%22Wallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrice%22%2C%22lastName%22%3A%22Chevallier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9my%22%2C%22lastName%22%3A%22Dulery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Forcade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Micha%22%2C%22lastName%22%3A%22Srour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Bazarbachi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Contentin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Lioure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabien%22%2C%22lastName%22%3A%22Tinquaut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claude-Eric%22%2C%22lastName%22%3A%22Bulabois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Therese%22%2C%22lastName%22%3A%22Rubio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Robin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques-Olivier%22%2C%22lastName%22%3A%22Bay%22%7D%5D%2C%22abstractNote%22%3A%22After%20chemotherapy%2C%20fewer%20than%2030%25%20of%20patients%20with%20T-cell%20lymphoma%20%28T-NHL%29%20are%20long-term%20disease-free%20survivors.%20Thus%2C%20there%20is%20a%20growing%20interest%20in%20allogeneic%20stem%20cell%20transplantation%20%28alloSCT%29%20and%20its%20potential%20graft-versus-lymphoma%20effect%20%28GVL%29%20for%20patient%20with%20high-risk%20or%20recurrent%20T-NHL%20with%20the%20aim%20at%20providing%20durable%20disease%20control%20in%20T-NHL.%20We%20conducted%20this%20registry%20study%20to%20evaluate%20the%20outcome%20of%20recipients%20of%20alternative%20donor%20alloSCT%20for%20T-NHL.%20Patients%20transplanted%20with%20Haploidentical%20donor%20%28Haplo%2C%20n%5Cu2009%3D%5Cu200941%29%20or%20Umbilical%20Cord%20Blood%20%28UCB%2C%20n%5Cu2009%3D%5Cu200954%29%20were%20analyzed%20for%20overall%20survival%20%28OS%29%2C%20non-relapse%20mortality%20%28NRM%29%2C%20relapse%2C%20and%20acute%5C%2Fchronic%20graft-versus-host%20disease%20%28aGVHD%5C%2FcGVHD%29%20incidence.%20At%202%20years%2C%20OS%20and%20PFS%20were%2C%20respectively%2C%20of%2059%25%20and%2053%25%2C%20without%20significant%20difference%20between%20Haplo%20and%20UCB.%20In%20multivariate%20analysis%2C%20disease%20status%20at%20transplant%20was%20an%20independent%20risk%20factor%20for%20OS%20and%20PFS%2C%20and%20aGVHD%20III%5Cu2013IV%20was%20the%20main%20factor%20for%20OS%20and%20NRM.%20While%20no%20major%20impact%20of%20donor%20source%20on%20survival%20and%20mortality%20was%20noted%2C%20this%20study%20suggests%20that%20alternative%20donor%20transplantation%20appears%20feasible%20and%20offers%20benefits%20to%20patients%20with%20T-cell%20lymphoma.%22%2C%22date%22%3A%222021-08-06%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41409-021-01426-3%22%2C%22ISSN%22%3A%221476-5365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41409-021-01426-3%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-10T03%3A22%3A48Z%22%7D%7D%5D%7D
Cornillon, J., Daguenet, E., Tournilhac, O., Blaise, D., NGuyen, S., Wallet, H. L., Chevallier, P., Dulery, R., Forcade, E., Srour, M., Bazarbachi, A., Contentin, N., Lioure, B., Tinquaut, F., Bulabois, C.-E., Rubio, M.-T., Robin, M., & Bay, J.-O. (2021). Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire. Bone Marrow Transplantation, 1–8. https://doi.org/10.1038/s41409-021-01426-3 Cite
